Drugs / Oxybutinin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01499069 | Feb 2010 → Nov 2015 | overactive bladder | Samsung Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxybutinin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01499069 ↗ |
| Action | Inhibit | “anti-muscarinic agent” NCT01499069 ↗ |